Drug Discovery Enzymes Market
Drug Discovery Enzymes R&D by Pharmaceuticals Opens Doors for the Major Players. Find Out More Trends with FMI
Drug Discovery Enzymes Market by Product Type, End User & Region - Forecast 2022 – 2032
Drug Discovery Enzymes Market Outlook (2022-2032)
[306 Pages Report] The drug discovery enzymes market is likely be worth US$ 1,776.8 million by 2032, from its projected US$ 886.6 million in 2022. A 6.5% CAGR in the market is predicted, during the forecast period. The drug discovery enzymes market experienced a CAGR of 6.4% over the preceding period (2016–2021).
The drug discovery enzymes market share is projected to rise as more sectors, including biotechnology, pharmaceuticals, food and beverage, embrace these enzymes for various analyses. These industries are concentrating on finding additional enzymes in order to develop useful medications.
|
Report Attribute |
Details |
|
Drug Discovery Enzymes Market Value (2022) |
US$ 886.6 Million |
|
Drug Discovery Enzymes Market Anticipated Value (2032) |
US$ 1,776.8 Million |
|
Drug Discovery Enzymes Projected Growth Rate (2032) |
6.5% |
The demand for drug discovery enzymes to produce intermediates for the manufacture of active pharmaceutical ingredients (API) for effective medications is rising. However, in recent years, the biofuel industry has made extensive use of enzymes like lipase to convert free fatty acids.
Let us know your requirement to get
100% FREE customization
What are the Factors Influencing the Drug Discovery Enzymes Market?
|
Factors |
Explanation |
|
R&D |
Companies in the pharmaceutical, biopharmaceutical, and medical device industries make significant investments in the creation of novel drugs and technologies that increase the adoption of drug discovery enzymes. However, in recent years, phase III and preclinical phases have received the lion's share of their funding. An increase in R&D spending is one of the main factors influencing the worldwide drug discovery enzymes market. The necessity for various preclinical and clinical services during the drug discovery and development process is what motivates the growth. |
|
Target Specific Drugs |
As manufacturers use enzymes to create more relevant medications that target certain areas of action, the market for drug discovery enzymes is anticipated to expand throughout the forecast period. Furthermore, to identify the R-ATA enzyme from soil bacteria, Kaneka Corporation and the University of Tokyo worked together in the biotechnology and development wing. |
|
Innovations |
The food business is using a finite amount of enzymes to extend food's shelf life and enhance flavor. MetXtra is a newly developed food enzyme in the market. The search for and production of novel enzymes for testing samples takes less time and money thanks to this new enzyme. During the anticipated period, these factors are likely to drive the demand for drug discovery enzymes to rise. However, in recent years, research institutions have innovated and focused on drug discovery enzymes to expand application domains. |
What are the Declining Factors in the Drug Discovery Enzymes Market?
Handling and safety hazards connected with enzymes, as well as increased sensitivity to temperature and pH, are expected to limit market expansion. Furthermore, high financial costs and difficulties in participant recruitment and retention slow down the market growth.
Additionally, deficiencies in the clinical research workforce, drug sponsor-imposed barriers, and barriers related to clinical research globalization may all harm the market growth.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystRegional Insights
Review Asia-Pacific Drug Discovery Enzymes Market
Asia-Pacific is expected to be the fastest-growing drug discovery enzymes market during the forecast period. However, due to the introduction of novel enzymes used to treat various chronic illnesses, and a rise in the number of development strategies by major companies, are rising market growth in the region.
Furthermore, the region is growing rapidly due to the availability of highly skilled labor with low-cost charges and due to environmental regulation in recent years.
What is the North America Drug Discovery Enzymes Market Outlook?
In terms of pharmaceutical R&D investment, North America dominates the drug discovery enzymes market during the forecast period. It is also the largest market for final dose formulations and bulk pharmaceuticals.
The market runs as a free economy, with transparent trading procedures and restrictions on anti-competitive behaviors. The region adopted high techniques with well-established infrastructure, which propelled the drug discovery enzymes market growth in recent years.
The United States market is expected to become one of the primary competitors for biosimilars by 2020. Remicade, Enbrel, Rituximab, Adalimumab, Infliximab, Etanercept, Darbepoetin Alpha, and other major medications are available in the US market. As a result of the aforementioned reasons, the market is expected to develop rapidly over the projected period.
Start-Up Ecosystem
How Start-Ups Companies Innovating in the Drug Discovery Enzymes Market?
To untangle the drug discovery process. Artificial intelligence and machine learning have given the pharmaceutical business new hope. AI tools enable researchers to rapidly develop innovative medications with the required features. Using these new methods, several businesses are developing innovative medicinal compounds. Some notable start-up companies are as under:
- Standigm: Standigm, a South Korean start-up formed in 2015, uses AI to identify medications, saving time and money when compared to traditional approaches. Standigm BEST, their AI platform, is designed to explore latent chemical space to develop unique compounds with required attributes. In addition to chemical data, they evaluate biological literature to accelerate de novo drug creation.
- Genesis Therapeutics: Genesis Therapeutics is a 2019 start-up situated in the United States. It combines artificial intelligence and biotechnology to speed the development of novel medications. For drug research and development, the business employs neural networks, biophysical modeling, and a scalable computing platform.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
What is the Competitive Analysis of the Drug Discovery Enzymes Market?
Various prominent players are researching drug discovery enzymes in recent years. The pharmaceutical scientists are developing several drug enzymes that help to cure patients’ critical diseases in recent years.
Some recent developments in the Drug Discovery Enzymes industry are as follows:
- In November 2020-Genesis Therapeutics and Genentech formed an AI-driven, multi-target drug development cooperation. Genesis' graph machine learning and drug discovery capabilities are used in this cooperation to uncover novel drug candidates for therapeutic targets across numerous disease categories.
- In January 2020, Bayer signed a collaborative deal with the artificial intelligence drug discovery business Exscientia to develop and optimize innovative lead structures for prospective therapeutic candidates in the treatment of cardiovascular and oncological illnesses.
Some of the Key Participants Present in the Global Drug Discovery Enzymes Market Include
- Sigma-Aldrich Co. LLC.
- Kaneka Corporation
- Actelion Pharmaceuticals Ltd
- Genesis Biotechnology Group
- Suven Life Sciences Limited
- Enzo Life Sciences, Inc.
- Merck KGaA
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 6.5% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments
By Product Type:
- Active Kinases
- Ubiquitin
- Epigenetic
- Methyltransferases
- Deacetylases
- Phosphodiesterases
- Others
By End User:
- Pharmaceutical and Biotechnology Company
- Research Institutes
- Other End User
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Frequently Asked Questions
The drug discovery enzymes market is predicted to advance at a CAGR of 6.5% from 2022-to 2032.
The North America is anticipated to lead the drug discovery enzymes market through 2032.
The drug discovery enzymes market is likely to hold a valuation of US$1,776.8 million by 2032.
Research & Development sector is the key driver in the drug discovery enzymes market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2016-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Active Kinases
5.3.2. Ubiquitin
5.3.3. Epigenetic
5.3.4. Methyltransferases
5.3.5. Deacetylases
5.3.6. Phosphodiesterases
5.3.7. Others
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2016-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2016-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
6.3.1. Pharmaceutical and Biotechnology Company
6.3.2. Research Institutes
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By End User, 2016-2021
6.5. Absolute $ Opportunity Analysis By End User, 2022-2032
7. Global Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Key Takeaways
10. Europe Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Product Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. India
11.2.1.5. Malaysia
11.2.1.6. Singapore
11.2.1.7. Australia
11.2.1.8. New Zealand
11.2.1.9. Rest of APAC
11.2.2. By Product Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End User
11.4. Key Takeaways
12. MEA Drug Discovery Enzymes Market Analysis 2016-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Product Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Drug Discovery Enzymes Market Analysis
13.1. U.S.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Product Type
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Product Type
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Product Type
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Product Type
13.4.2.2. By End User
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Product Type
13.5.2.2. By End User
13.6. U.K.
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Product Type
13.6.2.2. By End User
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Product Type
13.7.2.2. By End User
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Product Type
13.8.2.2. By End User
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Product Type
13.9.2.2. By End User
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Product Type
13.10.2.2. By End User
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Product Type
13.11.2.2. By End User
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Product Type
13.12.2.2. By End User
13.13. Malaysia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Product Type
13.13.2.2. By End User
13.14. Singapore
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Product Type
13.14.2.2. By End User
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Product Type
13.15.2.2. By End User
13.16. New Zealand
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Product Type
13.16.2.2. By End User
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Product Type
13.17.2.2. By End User
13.18. South Africa
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Product Type
13.18.2.2. By End User
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Product Type
13.19.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product Type
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Sigma-Aldrich Co. LLC.
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Kaneka Corporation
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Actelion Pharmaceuticals Ltd
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Enzo Life Sciences
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Merck KGaA
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Suven Life Sciences Limited
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Genesis Biotechnology Group
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Region, 2016-2032
Table 2: Global Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032
Table 3: Global Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032
Table 4: North America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 5: North America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032
Table 6: North America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032
Table 7: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 8: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032
Table 9: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032
Table 10: Europe Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 11: Europe Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032
Table 12: Europe Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032
Table 13: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 14: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032
Table 15: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032
Table 16: MEA Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 17: MEA Drug Discovery Enzymes Market Value (US$ Mn) Forecast by Product Type, 2016-2032
Table 18: MEA Drug Discovery Enzymes Market Value (US$ Mn) Forecast by End User, 2016-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032
Figure 2: Global Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032
Figure 3: Global Drug Discovery Enzymes Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Region, 2016-2032
Figure 5: Global Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032
Figure 8: Global Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 9: Global Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 10: Global Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032
Figure 11: Global Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 12: Global Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 13: Global Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032
Figure 14: Global Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032
Figure 15: Global Drug Discovery Enzymes Market Attractiveness by Region, 2022-2032
Figure 16: North America Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032
Figure 17: North America Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032
Figure 18: North America Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 20: North America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032
Figure 23: North America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 24: North America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 25: North America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032
Figure 26: North America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 27: North America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 28: North America Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032
Figure 29: North America Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032
Figure 30: North America Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032
Figure 32: Latin America Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032
Figure 33: Latin America Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 35: Latin America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032
Figure 38: Latin America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 39: Latin America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 40: Latin America Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032
Figure 41: Latin America Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 42: Latin America Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 43: Latin America Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032
Figure 44: Latin America Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032
Figure 45: Latin America Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032
Figure 46: Europe Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032
Figure 47: Europe Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032
Figure 48: Europe Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 50: Europe Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032
Figure 53: Europe Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 54: Europe Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 55: Europe Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032
Figure 56: Europe Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 57: Europe Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 58: Europe Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032
Figure 59: Europe Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032
Figure 60: Europe Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032
Figure 61: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032
Figure 62: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032
Figure 63: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032
Figure 64: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 65: Asia Pacific Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: Asia Pacific Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032
Figure 68: Asia Pacific Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 69: Asia Pacific Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 70: Asia Pacific Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032
Figure 71: Asia Pacific Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 72: Asia Pacific Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 73: Asia Pacific Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032
Figure 74: Asia Pacific Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032
Figure 75: Asia Pacific Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032
Figure 76: MEA Drug Discovery Enzymes Market Value (US$ Mn) by Product Type, 2022-2032
Figure 77: MEA Drug Discovery Enzymes Market Value (US$ Mn) by End User, 2022-2032
Figure 78: MEA Drug Discovery Enzymes Market Value (US$ Mn) by Country, 2022-2032
Figure 79: MEA Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 80: MEA Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: MEA Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: MEA Drug Discovery Enzymes Market Value (US$ Mn) Analysis by Product Type, 2016-2032
Figure 83: MEA Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 84: MEA Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 85: MEA Drug Discovery Enzymes Market Value (US$ Mn) Analysis by End User, 2016-2032
Figure 86: MEA Drug Discovery Enzymes Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 87: MEA Drug Discovery Enzymes Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 88: MEA Drug Discovery Enzymes Market Attractiveness by Product Type, 2022-2032
Figure 89: MEA Drug Discovery Enzymes Market Attractiveness by End User, 2022-2032
Figure 90: MEA Drug Discovery Enzymes Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
